Healthcare Publications Americas Orthopedic Biomaterial Market Research

Market Synopsis:
According to Market Research Future (MRFR)’s latest analysis, the Americas orthopedic
biomaterial market is set to thrive at a robust CAGR of 11.5% during the forecast period
2017 to 2023. The extensive use of biomaterials for internal fracture fixation is one of the
key factors responsible for the growth of the market.
The increasing orthopedic patient pool coupled with the exponential geriatric population is
expected to drive the proliferation of the Americas orthopedic biomaterial market.
Additionally, the rising rate of accidents causing bone injuries coupled with increasing count
of knee surgeries are likely to expedite the expansion of the Americas orthopedic
biomaterial market over the assessment period.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/641
The rising demand for hip replacement surgeries is another major factor projected to have a
positive impact on the expansion of the Americas orthopedic biomaterial market in the
forthcoming years. Furthermore, the growth of the orthopedic branch of medicine is
anticipated to reflect on the growth of the Americas orthopedic market over the next couple
of years.
The increasing patient pool has encouraged the government to take initiatives for increasing
awareness as well as seamless access to orthopedic surgeries. This, in turn, is projected to
augment the Americas orthopedic biomaterial market through the review period. Meanwhile,
factors such as high cost and failure of joint implants are poised to hold the growth of the
market in the next few years.
Competitive Dashboard:
Some of the key players profiled in this report are Carpenter Technology Corporation (US),
CeramTec (Germany), Ceradyne (US), Heraeus Medical Components (US), Purac
Biomaterials (US), Acumed (US), Amedica Corporation (US), Osteotech, Inc. (US), Cam
Bioceramics B.V. (Netherland), Materion Corporation (US), Ulbrich Stainless Steel & Special
Metals, Inc. (US), Kyocera Corporation (Japan), Ticona GmbH (Germany), Johnson &
Johnson (US), and Landec Corporation. (US).
Market Segmentation:
By material, the Americas orthopedic biomaterial market has been segmented into metals
and non-metals. The metals segment is further sub-segmented into stainless steel, Titanium
Alloy, Cobalt alloy, and others. The non-metals segment has been sub-segmented into
ceramic, polymeric, natural biomaterials and others.
By application, America’s orthopedic biomaterial market has been segmented into joint
replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation,
and others. The joint replacement segment has been sub-segmented into hip replacement,
knee replacement, shoulder and elbow replacement and others. The tissue fixation segment
has been sub-segmented into interference screws, suture anchors and others. The spine
implants segment is sub-segmented into spine fusion and others. The fracture fixation
devices segment has been sub-segmented into screws, plates for bones, rods, and others.
Regional Outlook:
The regional analysis of the Americas orthopedic biomaterial market spans across the U.S.,
Canada, and the Rest of America. The U.S. is the most significant country-level market of
the region and is poised to witness substantial growth in the forthcoming years. The growth
is attributable to the developments in the market coupled with rising number of joint
replacement surgeries. Furthermore, the presence of key players in the region is projected
to expedite the momentum of growth of the Americas orthopedic biomaterial market. Other
factors responsible for the swift proliferation of the market include rising healthcare
expenditure, technological advancements in the healthcare sector, hassle-free
reimbursement policies, etc.